PharmiWeb.com - Global Pharma News & Resources

riboxx pharmaceuticals

Research & Development

riboxx pharmaceuticals develops and manufactures GMP TLR3 ligands for immunotherapy of cancer or virus diseases. The drugs developed at riboxx belong to the class of Toll-like-Receptor 3 agonists (TLR3) and RIG-I-like-Receptor (RLR) agonists. The drug substance of these drugs is RNA (ribonucleic acid).